Radiotherapy Market Is Projected to Gain $11.9 Billion by 2031, Growing at a 6.3% CAGR: Allied Market Research

The global radiotherapy market is experiencing growth because of various factors, such as the rise in cancer, advancements in radiotherapy machinery, and the rise in the geriatric population. Based on region, the market across Asia-Pacific would portray the highest CAGR during the forecast period. 


Wilmington, Delaware, Nov. 13, 2023 (GLOBE NEWSWIRE) -- According to the recent report published by Allied Market Research, the global radiotherapy market size is projected to gain $11.9 billion by 2031, having endorsed a value of $6.5 billion in 2021, exhibiting a considerable CAGR of 6.3% from 2021 to 2030. This market report offers a comprehensive overview of the most prominent investment pockets, the top market segments, the current market dynamics, the market size and estimates, the competitive landscape, and regional insights. It is an essential resource for investors and shareholders, as well as for leading market players seeking to plan and strengthen their competitive edge. 

Request Sample of the Report on Radiotherapy Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/2367 

Report Coverage and Details:

Report Coverage Details 
Forecast Period 2021-2030 
Base Year 2021 
Market Size in 2021 $6.5 Billion  
Market Size in 2030 $11.9 Billion 
CAGR 6.3% 
No. of Pages in Report 210 
Segments Covered Type, End User, and Region 
Drivers Rise in cancer 
 Advancements in radiotherapy machinery 
 The rise in the geriatric population 
Restraints High cost of treatment 
 The potential side effects and risks associated with the use of certain medications 
Opportunities Technological advancements and innovation 
 The increase in the prevalence of cancer in developing countries 

Recent Developments in the Radiotherapy Market 

  • In January 2022, IBA (Ion Beam Applications) launched a new low energy and compact size cyclotron, the Cyclone KEY. This new machine is expected to enable small- and medium-sized hospitals to produce their own radiopharmaceutical products in-house, whilst providing more widespread global access to diagnostic solutions in oncology, neurology, and cardiology. 
  • In October 2021, Accuray Incorporated launched its new VOLO Ultra for the radixact system, at ASTRO 2021. VOLO Ultra is a new way of planning with the Accuray precision treatment planning system, which enables users to plan with ease, optimize with quality, and deliver treatments with efficiency. 
  • In September 2020, Elekta launched its Elekta Harmony, a linear accelerator (linac), which is used for cancer treatment. This system is designed to meet healthcare centers’ need for a productive, precise, and versatile radiotherapy treatment system. Harmony perfectly balances productivity, versatility, and precision without compromise, making it a solution for both, mature and developing markets. 
  • In June 2021, IBA (Ion Beam Applications) launched its new high energy and high-capacity cyclotron, the Cyclone IKON, which offers the largest energy spectrum for PET and SPECT isotopes from 13 MeV to 30 MeV. 

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/2367 

The global radiotherapy market is categorized into various segments based on type, end user, and region.  It is presented in both a tabular and graphical format, allowing individuals or businesses to gain visibility into the lucrative and rapidly growing segments. 

On the basis of type, the external beam radiation therapy segment accounted for the highest market share in 2021, contributing to around four-fifths of the global radiotherapy market. However, the internal radiation therapy segment would display the fastest CAGR of 7.8% from 2022 to 2031. The systemic radiation therapy market is also analyzed in the report. 

By end user, the hospitals and clinics segment garnered the major market share in 2021, accounting for around three-fifths of the global radiotherapy market, and is expected to retain its dominance throughout the forecast period. The others segment is also studied in the report. 

For Procurement Information - https://www.alliedmarketresearch.com/purchase-enquiry/2367 

Based on region, North America held the largest market share in 2021, acquiring around two-fifths of the global radiotherapy market. The Asia-Pacific region, on the other hand, would portray the highest CAGR of 7.4% from 2022 to 2031. The other provinces studied in the report are Europe and LAMEA. 

The report also provides an in-depth analysis of the prominent players in the global radiotherapy market including, Eckert & Ziegler Group, Siemens Healthineers AG, Accuray Incorporated, MEVION MEDICAL SYSTEMS, INC., Isoray, Inc., ICAD INC., Nordion Inc., Becton, Dickinson and Company, Elekta AB, and Ion Beam Applications SA. 

Comprehensive Healthcare Industry Research Studies: - 

Vegetarian Softgel Capsules Market - Global Opportunity Analysis and Industry Forecast, 2022–2032 

Upper Limb Prosthetics Market - Global Opportunity Analysis and Industry Forecast, 2022–2032 

Pediatric Neurology Device Market - Global Opportunity Analysis and Industry Forecast, 2022–2032 

Irritable Bowel Syndrome Treatment Market - Global Opportunity Analysis and Industry Forecast, 2022–2032 

Inhaled Nitric Oxide Market - Global Opportunity Analysis and Industry Forecast, 2022–2032    

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 
David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter